JVM Co

JVM Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JVM Co (054950.KQ) as of Nov 4, 2026 is 33.28 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 32.67 B KRW — a change of 1.84% (higher).

EBITDA

33.28 BKRW

YoY

1.84%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JVM Co is 2025 33.28 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JVM Co was 2024 32.67 B KRW. It decreases by 1.84% higher compared to the previous year.

The JVM Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
10.93 B KRW
Jan 1, 2019
8.18 B KRW
Jan 1, 2020
14.53 B KRW
Jan 1, 2021
13.04 B KRW
Jan 1, 2022
21.98 B KRW
Jan 1, 2023
31.72 B KRW
Jan 1, 2024
32.67 B KRW
Jan 1, 2025
33.28 B KRW
The JVM Co EBITDA history
YEAREBITDAYoY
33.28 BKRW+1.84%
32.67 BKRW+3.00%
31.72 BKRW+44.36%
21.98 BKRW+68.52%
13.04 BKRW-10.27%
14.53 BKRW+77.66%
8.18 BKRW-25.16%
10.93 BKRW-20.38%
13.73 BKRW-3.13%
14.17 BKRW+100.99%
7.05 BKRW-50.85%
14.34 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JVM Co is 33.28 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JVM Co changed from 32.67 B KRW to 33.28 B KRW, representing a 1.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) JVM Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — JVM Co

All Key Metrics — JVM Co